BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 26899852)

  • 1. Inflammasome as a New Therapeutic Target for Diabetic Complications.
    Volpe CM; Anjos PM; Nogueira-Machado JA
    Recent Pat Endocr Metab Immune Drug Discov; 2016; 10(1):56-62. PubMed ID: 26899852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic regulation of the NLRP3 inflammasome in chronic inflammatory diseases.
    Seok JK; Kang HC; Cho YY; Lee HS; Lee JY
    Arch Pharm Res; 2021 Jan; 44(1):16-35. PubMed ID: 33534121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting NLRP3 (Nucleotide-Binding Domain, Leucine-Rich-Containing Family, Pyrin Domain-Containing-3) Inflammasome in Cardiovascular Disorders.
    Wang Z; Hu W; Lu C; Ma Z; Jiang S; Gu C; Acuña-Castroviejo D; Yang Y
    Arterioscler Thromb Vasc Biol; 2018 Dec; 38(12):2765-2779. PubMed ID: 30571177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NLRP3 Inflammasome: Checkpoint Connecting Innate and Adaptive Immunity in Autoimmune Diseases.
    Zhang Y; Yang W; Li W; Zhao Y
    Front Immunol; 2021; 12():732933. PubMed ID: 34707607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new research hot spot: The role of NLRP3 inflammasome activation, a key step in pyroptosis, in diabetes and diabetic complications.
    Yu ZW; Zhang J; Li X; Wang Y; Fu YH; Gao XY
    Life Sci; 2020 Jan; 240():117138. PubMed ID: 31809715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting NLRP3 inflammasome as a promising approach for treatment of diabetic nephropathy: Preclinical evidences with therapeutic approaches.
    Ram C; Jha AK; Ghosh A; Gairola S; Syed AM; Murty US; Naidu VGM; Sahu BD
    Eur J Pharmacol; 2020 Oct; 885():173503. PubMed ID: 32858047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NLRP3 inflammasome as a potential treatment in ischemic stroke concomitant with diabetes.
    Hong P; Gu RN; Li FX; Xiong XX; Liang WB; You ZJ; Zhang HF
    J Neuroinflammation; 2019 Jun; 16(1):121. PubMed ID: 31174550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammasome in Dendritic Cells Immunobiology: Implications to Diseases and Therapeutic Strategies.
    Ferreira I; Liberal J; Martins JD; Silva A; Neves BM; Cruz MT
    Curr Drug Targets; 2017; 18(9):1003-1018. PubMed ID: 27660056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular Models and Assays to Study NLRP3 Inflammasome Biology.
    Zito G; Buscetta M; Cimino M; Dino P; Bucchieri F; Cipollina C
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32560261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orchestration of NLRP3 Inflammasome Activation by Ion Fluxes.
    Gong T; Yang Y; Jin T; Jiang W; Zhou R
    Trends Immunol; 2018 May; 39(5):393-406. PubMed ID: 29452983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of NLRP3 Inflammasome by Phosphorylation.
    Song N; Li T
    Front Immunol; 2018; 9():2305. PubMed ID: 30349539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NLRP3 inflammasome in ischemic stroke: As possible therapeutic target.
    Alishahi M; Farzaneh M; Ghaedrahmati F; Nejabatdoust A; Sarkaki A; Khoshnam SE
    Int J Stroke; 2019 Aug; 14(6):574-591. PubMed ID: 30940045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The NLRP3 Inflammasome as a Pharmacological Target.
    Marchetti C
    J Cardiovasc Pharmacol; 2019 Oct; 74(4):285-296. PubMed ID: 31335445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibiting the NLRP3 Inflammasome Activation with MCC950 Ameliorates Diabetic Encephalopathy in db/db Mice.
    Zhai Y; Meng X; Ye T; Xie W; Sun G; Sun X
    Molecules; 2018 Feb; 23(3):. PubMed ID: 29495433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NLRP3 inflammasome activation is associated with proliferative diabetic retinopathy.
    Loukovaara S; Piippo N; Kinnunen K; Hytti M; Kaarniranta K; Kauppinen A
    Acta Ophthalmol; 2017 Dec; 95(8):803-808. PubMed ID: 28271611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research Progress on the Role of Inflammasomes in Kidney Disease.
    Chi K; Geng X; Liu C; Cai G; Hong Q
    Mediators Inflamm; 2020; 2020():8032797. PubMed ID: 32410864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin: an inflammasome silencer.
    Hasanzadeh S; Read MI; Bland AR; Majeed M; Jamialahmadi T; Sahebkar A
    Pharmacol Res; 2020 Sep; 159():104921. PubMed ID: 32464325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
    Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
    Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammasomes contributing to inflammation in arthritis.
    Spel L; Martinon F
    Immunol Rev; 2020 Mar; 294(1):48-62. PubMed ID: 31944344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NLRP3 Inflammasome in Acute Myocardial Infarction.
    Mauro AG; Bonaventura A; Mezzaroma E; Quader M; Toldo S
    J Cardiovasc Pharmacol; 2019 Sep; 74(3):175-187. PubMed ID: 31356555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.